[1]
Sussman, G., Hebert, J., Gulliver, W., Lynde, C., Yang, W.H., Chambenoit, O., Vieira, A., De Takacsy, F. and Rihakova, L. 2017. Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s127. DOI:https://doi.org/10.25251/skin.1.supp.126.